Melatonin: A Safe Nutraceutical and Clinical Agent

作者: Edward H. Sharman , Stephen C. Bondy

DOI: 10.1016/B978-0-12-802147-7.00036-X

关键词:

摘要: Abstract Melatonin is an indoleamine with the chemical name N-acetyl-5-methoxytryptamine and found in animals, plants, bacteria. It has endocrine properties both animals plants. biosynthesized from neurotransmitter, serotonin, which turn made essential amino acid, tryptophan. Because its 5-hydroxy charged groups are acetylated, it a relatively nonpolar compound. In mammals, melatonin several roles; involved circadian regulation modulation of reproductive immune responses, mood, aging. produced by pineal gland peripheral tissues, notably gut. liberated into bloodstream pineal, can be considered systemic hormone. Levels vary diurnally, being highest during hours darkness, also throughout life cycle, lowest among elderly. This chapter focuses on recent findings suggesting variety therapeutic applications supporting safety exogenously supplied melatonin. The potential molecular mechanisms underlying these potentially clinically beneficial uses discussed.

参考文章(108)
Poluéktov Mg, Levin IaI, Spirin Nn, Doronin Bm, Boĭko An, Gustov Av, Skoromets Aa, Poverennova Ie, Iakupov Ez, Bel'skaia Gn, [The results of Russian multicenter open-label observational study of the efficacy and safety of мelaxen (melatonin) for the treatment of disordered sleep in patients with chronic cerebral ischemia]. Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova. ,vol. 112, pp. 26- 31 ,(2012)
Katherine A. Lyseng-Williamson, Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years. Drugs & Aging. ,vol. 29, pp. 911- 923 ,(2012) , 10.1007/S40266-012-0018-Z
Angelo Cagnacci, Renza Soldani, Samuel S.C. Yen, Exogenous melatonin enhances luteinizing hormone levels of women in the follicular but not in the luteal menstrual phase Fertility and Sterility. ,vol. 63, pp. 996- 999 ,(1995) , 10.1016/S0015-0282(16)57536-0
Stephen Bondy, Edward H. Sharman, Melatonin, Oxidative Stress, and the Aging Brain Humana Press, Totowa, NJ. pp. 339- 357 ,(2010) , 10.1007/978-1-60761-602-3_17
Ritva Lähteenmäki, Juha Puustinen, Tero Vahlberg, Alan Lyles, Pertti J. Neuvonen, Markku Partinen, Ismo Räihä, Sirkka-Liisa Kivelä, Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial British Journal of Clinical Pharmacology. ,vol. 77, pp. 975- 985 ,(2014) , 10.1111/BCP.12294
J. Liu, L.-n. Wang, Ramelteon in the treatment of chronic insomnia: systematic review and meta-analysis. International Journal of Clinical Practice. ,vol. 66, pp. 867- 873 ,(2012) , 10.1111/J.1742-1241.2012.02987.X
Pierre Lachapelle, Marie Dumont, Marianne Rufiange, Marianne Rufiange, Correlating retinal function with melatonin secretion in subjects with an early or late circadian phase. Investigative Ophthalmology & Visual Science. ,vol. 43, pp. 2491- 2499 ,(2002)
Russel J Reiter, Ahmet Korkmaz, Clinical aspects of melatonin. Saudi Medical Journal. ,vol. 29, pp. 1537- 1547 ,(2008)
Antonio George de Matos Cavalcante, Pedro Felipe Carvalhedo de Bruin, Veralice Meireles Sales de Bruin, Deuzilane Muniz Nunes, Eanes Delgado Barros Pereira, Marina Medeiros Cavalcante, Geanne Matos Andrade, None, Melatonin reduces lung oxidative stress in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study. Journal of Pineal Research. ,vol. 53, pp. 238- 244 ,(2012) , 10.1111/J.1600-079X.2012.00992.X